Chintan Parekh

1.3k total citations
34 papers, 814 citations indexed

About

Chintan Parekh is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Chintan Parekh has authored 34 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 13 papers in Molecular Biology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Chintan Parekh's work include Acute Lymphoblastic Leukemia research (10 papers), Acute Myeloid Leukemia Research (6 papers) and CAR-T cell therapy research (6 papers). Chintan Parekh is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Acute Myeloid Leukemia Research (6 papers) and CAR-T cell therapy research (6 papers). Chintan Parekh collaborates with scholars based in United States, India and Italy. Chintan Parekh's co-authors include Gay M. Crooks, Yuhua Zhu, Shundi Ge, Annie Luong, Vi Luan Ha, David Casero, Christopher S. Seet, Salemiz Sandoval, Jessica Scholes and Gopabandhu Jena and has published in prestigious journals such as Blood, Immunity and Nature Immunology.

In The Last Decade

Chintan Parekh

30 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chintan Parekh United States 13 341 243 185 163 163 34 814
Magdalena Baśkiewicz‐Masiuk Poland 11 331 1.0× 109 0.4× 129 0.7× 242 1.5× 157 1.0× 26 746
José Luís Fuster Spain 18 255 0.7× 163 0.7× 399 2.2× 184 1.1× 299 1.8× 60 937
Natalie V. Singer United States 10 251 0.7× 375 1.5× 165 0.9× 51 0.3× 154 0.9× 18 798
Guopan Yu China 14 214 0.6× 63 0.3× 428 2.3× 199 1.2× 130 0.8× 69 763
Tahsin Yakut Türkiye 15 315 0.9× 61 0.3× 76 0.4× 83 0.5× 88 0.5× 78 762
Mehrdad Noruzinia Iran 15 443 1.3× 139 0.6× 37 0.2× 80 0.5× 86 0.5× 71 810
Bechara Mfarrej United States 23 248 0.7× 937 3.9× 107 0.6× 88 0.5× 232 1.4× 42 1.5k
Virginie Éclache France 19 396 1.2× 228 0.9× 713 3.9× 504 3.1× 148 0.9× 68 1.2k
B A Dsupin United States 12 194 0.6× 412 1.7× 83 0.4× 77 0.5× 92 0.6× 14 1.4k
Yuki Fujioka Japan 13 386 1.1× 91 0.4× 115 0.6× 32 0.2× 110 0.7× 32 742

Countries citing papers authored by Chintan Parekh

Since Specialization
Citations

This map shows the geographic impact of Chintan Parekh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chintan Parekh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chintan Parekh more than expected).

Fields of papers citing papers by Chintan Parekh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chintan Parekh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chintan Parekh. The network helps show where Chintan Parekh may publish in the future.

Co-authorship network of co-authors of Chintan Parekh

This figure shows the co-authorship network connecting the top 25 collaborators of Chintan Parekh. A scholar is included among the top collaborators of Chintan Parekh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chintan Parekh. Chintan Parekh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luong, Annie, Andrew Doan, Lingyun Ji, et al.. (2025). T-cell dysfunction during blinatumomab therapy in pediatric acute lymphoblastic leukemia. Blood Advances. 9(15). 3689–3693. 1 indexed citations
2.
3.
Cheng, Bo, Steven Pastor, Tania B. Porras, et al.. (2024). Comparison of human pluripotent stem cell differentiation protocols to generate neuroblastoma tumors. Scientific Reports. 14(1). 23050–23050.
4.
Jambon, Samy, Sakunthala Muthugounder, Alexandra E. Kovach, et al.. (2024). CD33–CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells. Blood Cancer Discovery. 6(1). 55–72. 6 indexed citations
5.
Kovach, Alexandra E., Sara Silbert, Annie Luong, et al.. (2024). Monocytic Differentiation in B-Lymphoblastic Leukemia with CRLF2 rearrangement at Diagnosis: Implications for Pathogenesis and Post-Therapeutic Lineage Switch. Blood. 144(Supplement 1). 2799–2799.
6.
Le, Justin, Annie Luong, Andrew Doan, et al.. (2024). COVID ‐19 vaccinated children, adolescents, and young adults with acute lymphoblastic leukemia show spike reactive antibodies and multifunctional T‐cells. International Journal of Cancer. 155(12). 2190–2200.
7.
Sharpley, Mark S., Karolina Elżbieta Kaczor‐Urbanowicz, Patrick Chang, et al.. (2021). The Metabolic Landscape of Thymic T Cell Development In Vivo and In Vitro. Frontiers in Immunology. 12. 716661–716661. 18 indexed citations
8.
Le, Justin, Vi Luan Ha, Annie Luong, et al.. (2020). Single-Cell RNA-Seq Mapping of Human Thymopoiesis Reveals Lineage Specification Trajectories and a Commitment Spectrum in T Cell Development. Immunity. 52(6). 1105–1118.e9. 43 indexed citations
9.
Kim, Hye Na, Eun Ji Gang, Sajad Khazal, et al.. (2017). The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL. Cancers. 9(9). 121–121. 13 indexed citations
10.
Ha, Vi Luan, Annie Luong, David Casero, et al.. (2017). The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation. Leukemia. 31(11). 2503–2514. 41 indexed citations
11.
Casero, David, Salemiz Sandoval, Christopher S. Seet, et al.. (2015). Long non-coding RNA profiling of human lymphoid progenitor cells reveals transcriptional divergence of B cell and T cell lineages. Nature Immunology. 16(12). 1282–1291. 141 indexed citations
12.
Chung, Brile, Amélie Montel‐Hagen, Shundi Ge, et al.. (2014). Engineering the Human Thymic Microenvironment to Support Thymopoiesis In Vivo. Stem Cells. 32(9). 2386–2396. 41 indexed citations
13.
Ahmad, Tauseef, et al.. (2012). Pretreatment with valproic acid, a histone deacetylase inhibitor, enhances the sensitivity of the peripheral blood micronucleus assay in rodents. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 751(1). 19–26. 12 indexed citations
14.
Kohn, Lisa A., Qian‐Lin Hao, Rajkumar Sasidharan, et al.. (2012). Lymphoid priming in human bone marrow begins before expression of CD10 with upregulation of L-selectin. Nature Immunology. 13(10). 963–971. 82 indexed citations
15.
Parekh, Chintan & Gay M. Crooks. (2012). Critical Differences in Hematopoiesis and Lymphoid Development between Humans and Mice. Journal of Clinical Immunology. 33(4). 711–715. 62 indexed citations
16.
Khan, Sabbir, Tauseef Ahmad, Chintan Parekh, et al.. (2011). Investigation on sodium valproate induced germ cell damage, oxidative stress and genotoxicity in male Swiss mice. Reproductive Toxicology. 32(4). 385–394. 81 indexed citations
17.
Corselli, Mirko, Chintan Parekh, Elisa Montelatici, et al.. (2011). Vascular Pericytes Sustain Hematopoietic Stem Cells. Blood. 118(21). 2394–2394. 1 indexed citations
18.
Parekh, Chintan, Thomas Hofstra, Joseph A. Church, & Thomas D. Coates. (2010). Hemophagocytic lymphohistiocytosis in children with chronic granulomatous disease. Pediatric Blood & Cancer. 56(3). 460–462. 30 indexed citations
19.
Parekh, Chintan, Rima Jubran, Anat Erdreich‐Epstein, et al.. (2010). Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen. Journal of Neuro-Oncology. 103(3). 673–680. 35 indexed citations
20.
Parekh, Chintan. (2004). Study of Infant Feeding Practices: Factors Associated with Faulty Feeding. Journal of Tropical Pediatrics. 50(5). 306–308. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magdalena Baśkiewicz‐Masiuk Breakdown of academic impact, for papers by José Luís Fuster Breakdown of academic impact, for papers by Natalie V. Singer Breakdown of academic impact, for papers by Guopan Yu Breakdown of academic impact, for papers by Tahsin Yakut Breakdown of academic impact, for papers by Mehrdad Noruzinia Breakdown of academic impact, for papers by Bechara Mfarrej Breakdown of academic impact, for papers by Virginie Éclache Breakdown of academic impact, for papers by B A Dsupin Breakdown of academic impact, for papers by Yuki Fujioka
Rankless by CCL
2026